Increase in bone density and plasma osteocalcin during growth hormone therapy in growth hormone deficient children

Journal of Pediatric Endocrinology and Metabolism

Volumn 10, Issue 1, 1997, Pages 11-17

  Greig, Fenella ^a,c   Greenfield, Elizabeth ^a   Prasad, Vijaya ^a   AvRushkin, Theodore W ^a   Bastian, William ^b   Yasumura, Seiichi ^b   Castells, Salvador ^b  

^a BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; OSTEOCALCIN;

ADOLESCENT; ARTICLE; BONE DENSITY; BONE MATURATION; BONE MINERALIZATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OSTEOPENIA;

EID: 0030956078     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1997.10.1.11     Document Type: Article

References (27)

1. Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ. Bone mineral status in growth hormone deficiency. J Pediatr 1980; 96: 393-396.
2. Zamboni G, Antoniazzi F, Radetti G, Musumechi C, Tato L. Effects of two different regimens of recombinant human growth hormone on the bone mineral density of patients with growth hormone deficiency. J Pediatr 1991; 119: 483-485.
3. Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, DiNero G. Effects of long term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr 1993; 122: 37-45.
4. Henneman PH, Forbes AP, Moldawer M, Dempsey EF, Carroll EL. Effects of human growth hormone in man. J Clin Invest 1960; 39: 1223-1238.
5. Gertner JM, Horst RL, Broadus AE, Rasmussen H, Genel M. Parathyroid function and vitamin D metabolism during human growth hormone replacement. J Clin Endocrinol Metab 1979; 49: 185-188.
6. Harris WH, Heaney RP, Jowsey J, Cockin J, Akins C, Graham J, Weinberg EH. Growth hormone: the effect on skeletal renewal in the adult dog. Calc Tiss Res 1972; 10: 1-13.
7. Meunier PJ, Bressot C. Endocrine influences on bone cells and bone remodeling evaluated by clinical histomorphometry. In: Parsons JA, ed, Endocrinology of Calcium Metabolism. New York: Raven Press, 1992; 445-465.
8. Nishimoto SK, Price PA. Proof that the γ-carboxyglutamic acid-containing bone protein is synthesized in calf bone. J Biol Chem 1979; 254: 437-441.
9. Hauschka PV, Frenkel J, DeMuth R, Gundberg CM. Presence of osteocalcin and related high molecular weight 4-carboxy-γ-glutamic acid-containing proteins in developing bone. J Biol Chem 1983; 258: 176-180.
10. Price PA, Parthemore JG, Deftos LJ. New biochemical marker for bone metabolism: measurement by radio-immunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. J Clin Invest 1980; 66: 878-883.
11. Brown JP, Delmas PD, Malaval L, Eduoard C, Chapay MC, Meunier PJ. Serum bone γ-GLA protein: a specific marker for bone formation in post-menopausal osteoporosis. Lancet 12984; 1: 1091-1093.
12. Delmas PD, Chatelain P, Malaval L, Bonne G. Serum bone GLA-protein in growth hormone deficient children. J Bone Min Res 1986; 1: 333-338.
13. Johansen JS, Pedersen SA, Jørgensen JOL, Riis BJ, Christiansen C, Christiansen JS, Skakkebæk NE. Effects of growth hormone (GH) on plasma bone Gla protein in GH-deficient adults. J Clin Endocrinol Metab 1990; 70: 916-919.
14. Markowitz ME, DiMartino-Nardi J, Gasparini F, Fishman K, Rosen JF, Saenger P. Effects of growth hormone therapy on circadian osteocalcin rhythms in idopathic short stature. J Clin Endocrinol Metab 1989; 69: 420-425.
15. Hamill PVV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 1979; 32: 607-629.
16. Schalch DS, Parker ML. A sensitive double antibody immunoassay for human growth hormone in plasma. Nature 1964; 203: 1141-1145.
17. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist. 2nd Ed. Stanford, CA: Stanford University Press, 1959.
18. Gundberg CM, Lian JB, Gallop PM. Measurements of γ-carboxyglutamate and circulating osteocalcin in normal children and adults. Clin Chem Acta 1983; 128: 1-8.
19. Castells S, Yasumara S, Fusi MA, Colbert C, Bachtell R, Smith S. Plasma osteocalcin levels in patients with osteogenesis imperfecta. J Pediatr 1986; 109: 88-91.
20. Colbert C, Bachtell RS. Radiographic absorptiometry (photodensitometry). In: Cohn SH, ed, Non-Invasive Measurements of Bone Mass and their Clinical Application. Boca Raton, FL: CRC Press, 1981; 51-83.
21. Bachtell S. Bone mineral density norms for children generated from National Center for Health Statistics radiographs. Clinical Radiology Testing Laboratory Report No. 184; 1988: 1-16.
22. Inzucchi SE, Robbins RJ. Clinical review: Effects of growth hormone on human bone biology. J Clin Endocrinol Metab 1994; 79: 691-694.
23. Kaufman JM, Toelman P, Vermeulen A, Vanderweghe M. Bone mineral status in growth hormone deficient males with isolated and multiple pituitary deficiences of childhood onset. J Clin Endocrinol Metab 1992; 74: 118-123.
24. Zanzi I, Colbert C, Bachtell R, Thompson K, Aloia J, Cohn S. Comparison of total body calcium with radiographic and photon absorptiometry measurements of appendicular bone mineral content. Am J Roentgenol 1978; 131: 551 (Abst).
25. Rosenthal DI, Gregg GA, Slovik DM, Neer RM. A comparison of quantitative computer tomography to four techniques of upper extremity bone mass measurements in: Genant HK, ed, Osteoporosis Update 1987. Berkeley, CA: University of California Press, 1987; 87-93.
26. DeBoer H, Blok GJ, Van Lingen A, Teule GJJ, Lips P, Van deer Veen EA. Consequences of childhood onset growth hormone deficiency for adult bone mass. J Bone Miner Res 1994; 9: 1319-1326.
27. Kanzaki S, Hosoda K, Moriwake T, Tanaka H, Kubo T, Inoue M, Higuchi J, Yamaji T. Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone deficiency: a potential marker of bone growth and response to GH therapy. J Clin Endocrinol Metab 1992; 75: 1104-1109.